A team of researchers has developed a technique for diagnosing, managing and treating neurological disorders with minimal surgical risks.

Researchers have developed an optical biosensor that detects the virus that causes mpox. The technology could make diagnosis much faster and cost-effective as the disease continues to spread worldwide ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

Researchers have developed an innovative electrochemical reactor to extract lithium from natural brine solutions, offering a promising approach to address the growing demand for lithium used in ...

A new study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Mobile phones could be the key to a cheaper and more reliable way of tracking animals for ecology and conservation research, according to a new study.

The interplay between the genetic makeup of crops and the conditions in which they grow is difficult to untangle. A research team aims to help breeders analyze the interactions to make crops more ...

Planktonic foraminifera are tiny marine organisms, which are essential to the ocean's carbon cycle. A recent study reveals that these populations are shrinking at an alarming rate due to ocean warming ...

The research also highlights potential avenues for repurposing existing drugs. Researchers found that trimethoprim and sulfamethoxazole, antibiotics used to treat other diseases, were also effective ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.